Literature DB >> 15361237

Toward an understanding of the interaction between filarial parasites and host antigen-presenting cells.

Roshanak Tolouei Semnani1, Thomas B Nutman.   

Abstract

Lymphatic filarial infection, from an immunologic point of view, is one of the most complex parasite infections. Not only are there different clinical manifestations that reflect differing immune responses, but the parasite's multiple stages, each with distinct anatomic tropism, add a compartmental layer of complexity to an already complicated process. Moreover, these parasites have finely tuned immune evasion strategies that enable escape from the innate immune system. As different stages of the parasite interact with different types of antigen-presenting cells that, in turn, may play a significant role in shaping the subsequent adaptive immune response, the focus of this review is to provide insight into the interaction between filarial parasites and antigen-presenting cells with an eye toward understanding how they influence parasite antigen-driven T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361237     DOI: 10.1111/j.0105-2896.2004.00196.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  18 in total

1.  Filarial lymphatic pathology reflects augmented toll-like receptor-mediated, mitogen-activated protein kinase-mediated proinflammatory cytokine production.

Authors:  Subash Babu; R Anuradha; N Pavan Kumar; P Jovvian George; V Kumaraswami; Thomas B Nutman
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

Review 2.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

3.  Functional Impairment of Murine Dendritic Cell Subsets following Infection with Infective Larval Stage 3 of Brugia malayi.

Authors:  Aditi Sharma; Pankaj Sharma; Achchhe Lal Vishwakarma; Mrigank Srivastava
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

4.  Toll-like receptor- and filarial antigen-mediated, mitogen-activated protein kinase- and NF-κB-dependent regulation of angiogenic growth factors in filarial lymphatic pathology.

Authors:  Subash Babu; R Anuradha; N Pavan Kumar; P Jovvian George; V Kumaraswami; Thomas B Nutman
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

5.  Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes.

Authors:  Subash Babu; V Kumaraswami; Thomas B Nutman
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Recombinant Brugia malayi pepsin inhibitor (rBm33) induced monocyte function and absence of apoptotic cell death: an in vitro study.

Authors:  Kirthika Sreenivas; Kamalakannan Vijayan; Subash Babu; Rangarajan Badri Narayanan
Journal:  Microb Pathog       Date:  2012-03-30       Impact factor: 3.738

7.  Alternatively activated and immunoregulatory monocytes in human filarial infections.

Authors:  Subash Babu; V Kumaraswami; Thomas B Nutman
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

Review 8.  Helminth-Tuberculosis Co-infection: An Immunologic Perspective.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Trends Immunol       Date:  2016-08-05       Impact factor: 16.687

9.  Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1.

Authors:  Subash Babu; Sajid Q Bhat; N Pavan Kumar; S Jayantasri; S Rukmani; Paul Kumaran; P G Gopi; C Kolappan; V Kumaraswami; Thomas B Nutman
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

10.  Inflammatory responses to migrating Brugia pahangi third-stage larvae.

Authors:  Kristina H Porthouse; Sharon R Chirgwin; Sharon U Coleman; H Wayne Taylor; Thomas R Klei
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.